drugset / Trial / NCT01023230
A Study to Assess DV-601 in Subjects With Chronic Hepatitis B
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine if DV-601, an investigational, therapeutic vaccine will be well-tolerated and induce hepatitis B virus (HBV)-specific virological and immunological responses in chronic hepatitis B (CHB) patients.
Timeline
- Start
- 2009-09
- Primary completion
- 2011-05
- Completion
- 2011-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | DV-601 | Vaccine | — | — |
| Background | Entecavir | Small molecule | — | — |